PL2952203T3 - Sposób przygotowania ludzkiej albuminy o obniżonej zawartości rozpuszczalnego tlenu - Google Patents

Sposób przygotowania ludzkiej albuminy o obniżonej zawartości rozpuszczalnego tlenu

Info

Publication number
PL2952203T3
PL2952203T3 PL15382164T PL15382164T PL2952203T3 PL 2952203 T3 PL2952203 T3 PL 2952203T3 PL 15382164 T PL15382164 T PL 15382164T PL 15382164 T PL15382164 T PL 15382164T PL 2952203 T3 PL2952203 T3 PL 2952203T3
Authority
PL
Poland
Prior art keywords
preparation
dissolved oxygen
human albumin
reduced level
albumin
Prior art date
Application number
PL15382164T
Other languages
English (en)
Polish (pl)
Inventor
Nieto Juan Ignacio Jorquera
Fernández Ana Maria Ortiz
Rierola Montserrat Costa
Original Assignee
Grifols, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52003454&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2952203(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols, S.A. filed Critical Grifols, S.A.
Publication of PL2952203T3 publication Critical patent/PL2952203T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL15382164T 2014-05-29 2015-04-01 Sposób przygotowania ludzkiej albuminy o obniżonej zawartości rozpuszczalnego tlenu PL2952203T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201430824A ES2524516B1 (es) 2014-05-29 2014-05-29 Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido

Publications (1)

Publication Number Publication Date
PL2952203T3 true PL2952203T3 (pl) 2017-02-28

Family

ID=52003454

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15382164T PL2952203T3 (pl) 2014-05-29 2015-04-01 Sposób przygotowania ludzkiej albuminy o obniżonej zawartości rozpuszczalnego tlenu

Country Status (22)

Country Link
US (1) US10350274B2 (https=)
EP (1) EP2952203B9 (https=)
JP (3) JP2015224251A (https=)
KR (1) KR101960729B1 (https=)
CN (1) CN105315362B (https=)
AR (1) AR100618A1 (https=)
AU (1) AU2015202413B2 (https=)
BR (1) BR102015012091A8 (https=)
CA (1) CA2890642C (https=)
CL (1) CL2015001446A1 (https=)
ES (2) ES2524516B1 (https=)
HU (1) HUE031823T2 (https=)
IL (1) IL238898B (https=)
MX (1) MX362869B (https=)
MY (1) MY171771A (https=)
NZ (1) NZ708537A (https=)
PL (1) PL2952203T3 (https=)
PT (1) PT2952203T (https=)
RU (1) RU2657578C2 (https=)
SG (1) SG10201504137PA (https=)
TW (1) TWI607018B (https=)
ZA (1) ZA201503539B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
ES2900302T3 (es) 2016-04-28 2022-03-16 Alkahest Inc Fracciones de plasma como terapia para el crecimiento y la progresión del tumor
SMT202100666T1 (it) 2016-08-18 2022-01-10 Alkahest Inc Frazioni di plasma sanguigno come trattamento per disturbi cognitivi associati all'invecchiamento
WO2018200560A1 (en) 2017-04-26 2018-11-01 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
MA53182A (fr) 2018-07-20 2021-05-26 Alkahest Inc Schéma posologique pour le traitement de déficiences cognitives et motrices avec du plasma sanguin et des produits à base de plasma sanguin
CN119345230A (zh) 2018-10-26 2025-01-24 万能溶剂有限公司 血浆和血浆组分用于改善疼痛的用途
CN109627322A (zh) * 2019-01-07 2019-04-16 中国科学院过程工程研究所 一种从Cohn组分Ⅴ上清中分离纯化人血清白蛋白的方法
JP2022553837A (ja) 2019-11-04 2022-12-26 アルカヘスト,インコーポレイテッド 筋肉再生に使用するための血漿画分
AU2020388572A1 (en) 2019-11-20 2022-05-26 Alkahest, Inc. Blood plasma fractions for use in liver regeneration
WO2024200553A1 (en) 2023-03-29 2024-10-03 Grifols Worldwide Operations Limited COMPOSITIONS AND METHODS OF PREPARATION OF BLOOD PLASMA PRODUCTS WITH REDUCED LEVELS OF FceRIß AUTOANTIBODIES
CN118166053B (zh) * 2024-03-15 2025-02-07 通化安睿特生物制药股份有限公司 一种制备低o-糖基化水平的重组人白蛋白的方法
WO2025230830A1 (en) 2024-04-29 2025-11-06 Alkahest, Inc. Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
SE9402119D0 (sv) * 1994-06-16 1994-06-16 Pharmacia Ab Solution
US5766582A (en) * 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
JP4254117B2 (ja) * 2001-03-27 2009-04-15 ニプロ株式会社 アルブミン溶液収容プラスチック容器
DE60234142D1 (de) * 2001-03-27 2009-12-10 Nipro Corp Albuminlösung enthaltender Kunststoffbehälter
WO2003002139A1 (fr) * 2001-06-29 2003-01-09 Asahi Kasei Kabushiki Kaisha Procede permettant d'ameliorer la stabilite de la preparation de proteines
US7252799B2 (en) * 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US7285379B2 (en) * 2003-08-28 2007-10-23 Nipro Corporation Artificial oxygen carrier and production method thereof
HRP20120994T1 (hr) * 2006-02-07 2012-12-31 Shire Human Genetic Therapies, Inc. Stabilizirana smjesa glukocerebrozidaze
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
JP5990880B2 (ja) * 2011-08-31 2016-09-14 東レ株式会社 有用タンパク質組成物およびその製造方法
CN102816230B (zh) * 2012-08-27 2014-02-12 同路生物制药股份有限公司 人血白蛋白的制备方法
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido

Also Published As

Publication number Publication date
ZA201503539B (en) 2017-01-25
TW201544510A (zh) 2015-12-01
HUE031823T2 (en) 2017-08-28
MX2015006407A (es) 2015-11-30
SG10201504137PA (en) 2015-12-30
AU2015202413A1 (en) 2015-12-17
CN105315362B (zh) 2019-10-25
EP2952203B9 (en) 2018-03-14
RU2015118453A (ru) 2016-12-10
KR101960729B1 (ko) 2019-03-21
ES2524516B1 (es) 2015-03-31
KR20160024348A (ko) 2016-03-04
JP2020111614A (ja) 2020-07-27
EP2952203B1 (en) 2016-10-26
TWI607018B (zh) 2017-12-01
CL2015001446A1 (es) 2016-05-13
MY171771A (en) 2019-10-29
ES2601137T3 (es) 2017-02-14
US20150343025A1 (en) 2015-12-03
AR100618A1 (es) 2016-10-19
BR102015012091A8 (pt) 2021-03-16
US20170000855A9 (en) 2017-01-05
PT2952203T (pt) 2016-11-23
NZ708537A (en) 2017-06-30
CA2890642C (en) 2019-02-12
US10350274B2 (en) 2019-07-16
BR102015012091A2 (pt) 2016-01-05
ES2524516A1 (es) 2014-12-09
JP2015224251A (ja) 2015-12-14
RU2657578C2 (ru) 2018-06-14
IL238898B (en) 2018-01-31
JP2018115210A (ja) 2018-07-26
MX362869B (es) 2019-02-20
AU2015202413B2 (en) 2017-08-31
CN105315362A (zh) 2016-02-10
CA2890642A1 (en) 2015-11-29
EP2952203A1 (en) 2015-12-09

Similar Documents

Publication Publication Date Title
IL279627A (en) A method for treating depression
SG10201504137PA (en) Method For The Preparation Of Human Albumin With Reduced Level Of Dissolved Oxygen
IL251560A0 (en) Methods for preparing ribosides
IL250070A0 (en) A walk-up chair
SG11201703928QA (en) Patient interface
AU358462S (en) Patient interface
PL4137188T3 (pl) Interfejs do współpracowania z pacjentem
EP3167920A4 (en) Blood circulation system
PT3174988T (pt) Método para a preparação de ácido láctico
IL258922A (en) Methods for the preparation of obeticholic acid and derivatives thereof
PT3020430T (pt) Cânula para terapia de implantação de sutura catgut
SG11201702700UA (en) Methods for the treatment of peri-implantitis
EP3106128A4 (en) Artificial blood vessel
GB2519228B (en) Wheelchair
IL259073A (en) History of abscisic acid - converted at the 3' position
GB2538767B (en) Coffin
IL249463A0 (en) Production method for (s)-2-acetyloxypropionic acid and their derivatives
HUE038273T2 (hu) Koporsó
TWM532856U (en) Combined coffin structure
EP3181093A4 (en) Artificial blood vessel
ZA201802926B (en) Electrocatalyst for the reduction of oxygen
GB201503737D0 (en) Red funeral hearse
AU359444S (en) Wheelchair antitip part
GB201505487D0 (en) Method for ascertaining the vertical position of tissue structure
IL240634A0 (en) Wheelchair